Article Information
History
- October 30, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Rofhiwa Nesamari1,2,
- Millicent A. Omondi1,2,
- Maxine A. Höft1,2,
- Amkele Ngomti1,2,
- Richard Baguma1,2,
- Anathi A. Nkayi1,2,
- Asiphe S. Besethi1,2,
- Siyabulela F. J. Magugu1,2,
- Paballo Mosala1,2,
- Avril Walters1,2,
- Gesina M. Clark1,2,
- Mathilda Mennen3,4,5,
- Sango Skelem3,4,5,
- Marguerite Adriaanse3,4,5,
- Alba Grifoni6,
- Alessandro Sette6,7,
- Roanne S. Keeton1,2,
- Ntobeko A.B. Ntusi1,3,4,5,8,
- Catherine Riou1,2,8,9,* and
- Wendy A. Burgers1,2,8,9,10,*
- 1Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
- 2Division of Medical Virology, Department of Pathology, University of Cape Town. Cape Town, South Africa
- 3Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa
- 4Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
- 5South African Medical Research Council Extramural Unit on Intersection of Non-communicable Diseases and Infectious Diseases, University of Cape Town, Cape Town, South Africa
- 6Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, California, USA
- 7Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, California, USA
- 8Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Cape Town, South Africa
- ↵*Correspondence: wendy.burgers{at}uct.ac.za (W.A.B.), cr.riou{at}uct.ac.za (C.R.)
↵9 These authors contributed equally.
Posted October 30, 2023.
Post-pandemic memory T-cell response to SARS-CoV-2 is durable, broadly targeted and cross-reactive to hypermutated BA.2.86
